Marked augmentation of PLGA nanoparticle-induced metabolically beneficial impact of γ-oryzanol on fuel dyshomeostasis in genetically obese-diabetic ob/ob mice. [electronic resource]
Producer: 20170403Description: 558-568 p. digitalISSN:- 1521-0464
- Administration, Oral
- Animals
- Behavior, Animal -- drug effects
- Blood Glucose -- drug effects
- Diabetes Mellitus -- blood
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Carriers
- Drug Compounding
- Endoplasmic Reticulum Stress -- drug effects
- Energy Metabolism -- drug effects
- Food Preferences -- drug effects
- Gastrointestinal Microbiome -- drug effects
- Hypoglycemic Agents -- administration & dosage
- Hypolipidemic Agents -- administration & dosage
- Insulin Resistance
- Intestinal Absorption
- Islets of Langerhans -- drug effects
- Lactic Acid -- administration & dosage
- Lipids -- blood
- Liver -- drug effects
- Male
- Mice, Obese
- Nanomedicine
- Nanoparticles
- Obesity -- blood
- Phenylpropionates -- administration & dosage
- Polyglycolic Acid -- administration & dosage
- Polylactic Acid-Polyglycolic Acid Copolymer
- Solubility
- Technology, Pharmaceutical -- methods
- Time Factors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.